Visicol

Constipation, Hypophosphatemia, Parenteral Nutrition, Total + 4 more
Treatment
1 FDA approval
20 Active Studies for Visicol

What is Visicol

Sodium phosphate, dibasicThe Generic name of this drug
Treatment SummarySodium phosphate is a type of medication that helps to stimulate a bowel movement by increasing fluid in the small intestine. It usually takes between 30 minutes and 6 hours for the laxative to work.
K Phos Neutralis the brand name
image of different drug pills on a surface
Visicol Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
K Phos Neutral
Sodium phosphate, dibasic
1977
15

Approved as Treatment by the FDA

Sodium phosphate, dibasic, also known as K Phos Neutral, is approved by the FDA for 1 uses which include Parenteral Nutrition, Total .
Parenteral Nutrition, Total

Effectiveness

How Visicol Affects PatientsSodium phosphate makes stools softer and easier to pass through the large intestine.
How Visicol works in the bodySodium phosphate is believed to work by adding more substances to the intestines, which causes an imbalance of water in the intestine. This imbalance draws in more water, creating a gradient that helps speed up the intestines.

When to interrupt dosage

The prescribed dosage of Visicol is contingent upon the indicated condition, including fluid and electrolyte upkeep treatment, Fluid substitution therapy and Irrigation. The quantity of dosage is subject to the technique of administration (e.g. Liquid or Tablet, coated) laid out in the table below.
Condition
Dosage
Administration
Parenteral Nutrition, Total
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation
severe constipation
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation
Surgical Procedures
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation
Constipation
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation
Bowel preparation therapy
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation
Colonoscopy
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation
Hypophosphatemia
, 10.0 mL, 195.0 mg, 0.0875 mg/mL, 398.0 mg, 0.84 %, 852.0 mg, 142.0 mg/mL, 0.034 mL/mL, 0.187 mg/mL, 0.493 mg/mL, 350.0 mg/mL, 70.0 mg/mL, 0.042 %, 180.0 mg/mL, 900.0 mg/mL, 60.0 mg/mL, 4.3 mg/mL, 4.1 mg/mL, 0.01 mg/mg, 0.49 mg/mL, 0.42 mg/mL, 1.242 mg/mL, 0.12 mg/mL, 0.28 mg/mL, 3.05 mg/mL, 7.58 mg/mL, 268.0 mg/mL, 356.9575 mg/mL
, Irrigation, Irrigant, Irrigant - Irrigation, Buccal, Spray, Spray - Buccal, Intravenous, Liquid, Kit, Liquid - Buccal, Kit - Intravenous, Oral, Tablet, effervescent - Oral, Tablet, effervescent, Liquid - Irrigation, Solution, Solution - Intravenous, Liquid - Topical, Topical, Tablet, Tablet - Oral, Respiratory (inhalation), Solution - Respiratory (inhalation), Solution - Oral, Liquid - Oral, Rectal, Enema, Enema - Rectal, Tablet, coated, Tablet, coated - Oral, Injection, solution - Intravenous, Injection, solution, Solution - Irrigation, Injection, Injection - Intravenous, Powder, Powder - Oral, Intraocular, Kit; Solution, Kit; Solution - Intraocular, Powder, for solution, Powder, for solution - Intraocular, Intraocular; Irrigation, Kit; Solution - Intraocular; Irrigation

Warnings

Visicol has four contraindications and should not be used in coordination with the conditions given in the following table.There are 20 known major drug interactions with Visicol.
Common Visicol Drug Interactions
Drug Name
Risk Level
Description
Alloin
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Alloin.
Calcium polycarbophil
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Calcium polycarbophil.
Chlorpropamide
Minor
Sodium phosphate, dibasic may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Frangula purshiana bark
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Frangula purshiana bark.
Konjac mannan
Minor
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Konjac mannan.
Visicol Toxicity & Overdose RiskRats have a lethal dose of sodium phosphate of 250mg/kg when given intramuscularly and 8290mg/kg when given orally. High levels of phosphate in the body can cause tetany, dehydration, low blood pressure, rapid heartbeat, extreme fever, and even coma. Smaller patients are more at risk for experiencing phosphate toxicity.
image of a doctor in a lab doing drug, clinical research

Visicol Novel Uses: Which Conditions Have a Clinical Trial Featuring Visicol?

54 active clinical trials are ongoing to investigate the efficacy of Visicol in providing Electrolyte replacement, proctoscopy and Irrigation for treatment of certain conditions.
Condition
Clinical Trials
Trial Phases
Bowel preparation therapy
2 Actively Recruiting
Phase 1, Phase 2, Not Applicable
Hypophosphatemia
2 Actively Recruiting
Early Phase 1, Phase 2
Constipation
35 Actively Recruiting
Phase 3, Phase 2, Not Applicable, Phase 4, Early Phase 1
severe constipation
0 Actively Recruiting
Parenteral Nutrition, Total
0 Actively Recruiting
Colonoscopy
4 Actively Recruiting
Not Applicable, Phase 4
Surgical Procedures
0 Actively Recruiting

Visicol Reviews: What are patients saying about Visicol?

5Patient Review
1/2/2009
Visicol for Emptying of the Bowel
Easy to use, and the pills went down easily. I was worried about taking so many at once, but it wasn't a problem.
4Patient Review
11/30/2007
Visicol for Emptying of the Bowel
I experienced an irregular heartbeat and low potassium levels in my blood.
2Patient Review
3/20/2009
Visicol for Emptying of the Bowel
Unfortunately, this caused me a lot of pain and vomiting. I'm still dealing with the after-effects weeks later.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about visicol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Visicol used for?

"The VISICOL colonoscopy prep medication is only to be used by adults aged 18 and over. It works by causing diarrhea, which in turn cleans out the colon before the procedure. This is important because it allows your doctor to get a better view of the inside of the colon."

Answered by AI

Is Visicol still on the market?

"This product is no longer available under the Visicol name. If the FDA has approved generic versions of this product, there may be generic equivalents available."

Answered by AI

Clinical Trials for Visicol

Have you considered Visicol clinical trials? We made a collection of clinical trials featuring Visicol, we think they might fit your search criteria.
Have you considered Visicol clinical trials? We made a collection of clinical trials featuring Visicol, we think they might fit your search criteria.
Have you considered Visicol clinical trials? We made a collection of clinical trials featuring Visicol, we think they might fit your search criteria.